The roles of transforming growth factor type β3(TGF-β3) and mast cells in the pathogenesis of scleroderma

Clinical Rheumatology

Volumn 22, Issue 3, 2003, Pages 189-195

  Kemal Ozbilgin, M ^a   Inan, Sevinc ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Mast cell; Scleroderma; TGF

Indexed keywords

COLLAGEN; TOLONIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; ARTICLE; CELL SUBPOPULATION; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DERMIS; ELECTRON MICROSCOPE; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; IMMUNOREACTIVITY; MALE; MAST CELL; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; SCLERODERMA; SKIN BIOPSY; SKIN FIBROSIS; STATISTICAL SIGNIFICANCE; TRANSMISSION ELECTRON MICROSCOPY;

ADULT; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CELL MOVEMENT; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAST CELLS; MICROSCOPY, ELECTRON; MIDDLE AGED; PHOTOMICROGRAPHY; PROGNOSIS; REFERENCE VALUES; SCLERODERMA, LOCALIZED; SENSITIVITY AND SPECIFICITY; SKIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3;

EID: 0141928108     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-003-0706-5     Document Type: Article

References (34)

1. Fitzpatrick's dermatology in general medicine, 5th edn. Vol. 2. McGraw-Hill, 1999; 2023-2033
2. Mayers MD (1996) Scleroderma epidemiology. Rheum Dis Clin North Am 22: 751-756
3. Furst DE, Clements PJ (1997) Hypothesis for the pathogenesis of systemic sclerosis. J Rheumatol 48(Suppl ): 53-57
4. Hoyland JA, Newson L, Jayson MIV, Freemont J (1993) The vascular basement membrane in systemic sclerosis skin: heterogeneity of type IV collagen. Br J Dermatol 129: 384-388
5. Kahaleh MB, Yin T (1990) The molecular mechanisms of endothelial cell injury in scleroderma. Arthritis Rheum 33: S21
6. Krieg T, Perlish JS, Fleischmajer R, Braun-Falco O (1985) Collagen synthesis in scleroderma: selection of fibroblast populations during subcultures. Arch Dermatol Res 277: 373-376
7. Marks RM, Roche WR, Czerniecki M, Penny R, Nelson DS (1986) Mast cell granules cause proliferation of human microvascular endothelial cells. Lab Invest 55: 289-294
8. Lichtbroun AS, Sandhaus LM, Giorno RC, Kim H, Seibold JR (1990) Myocardial mast cells in systemic sclerosis: A report of three fatal cases. Am J Med 89: 372-6
9. Hawkins RA, Claman HN, Clark RAF, Steigerwald JC (1985) Increased dermal mast cell populations in progressive systemic sclerosis: A link in chronic fibrosis? Ann Intern Med 102: 182-186
10. Yamamoto T, Katayama I, Nishioka K (1998) Statement of stem cell factor in the lesional skin of systemic sclerosis. Dermatology 197: 109-114
11. Kahari VM, Sandberg M, Kalimo H (1988) Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization. J Invest Dermatol 90: 644-670
12. Lee Choi K, Claman HN (1987) Mast cells, fibroblasts and fibrosis. New clues to the riddle of mast cells. Immunol Res 6: 145-152
13. Massague J (1990) The transforming growth factor -β family. Annu Rev Cell Biol 6: 597-641
14. Border WA, Ruoslahti E. (1992) Transforming growth factor-β in disease. The dark side of tissue repair. J Clin Invest 90: 1-7
15. Gruschwitz M, Müller PU, Sepp N, Hofer E, Fontana A, Wick G (1990) Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: A mediator of fibrosis. J Invest Dermatol 94: 197-203
16. Kawakami T, Ihn H, Xu W et al. (1998) Increased expression of TGF-β receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-β signaling to scleroderma phenotype. J Invest Dermatol 110: 47-51
17. Kawakami T, Soma Y, Mizoguchi M, Saito R (2000) Immunohistochemical expression of transforming growth factor β in calcinosis in a patient with systemic sclerosis and CREST syndrome. Br J Dermatol 143: 1097-1131
18. Falanga V, Julien JM (1990) Observations in the potential role of transforming growth factor-β in cutaneous fibrosis. Systemic sclerosis. Ann NY Acad Sci 593: 161-171
19. Roberts AB, Sporn M, Assoian RK et al. (1986) Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83: 4167-4171
20. Ignotz RA, Massague J (1987) Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261: 4337-4345
21. Cotton SA, Herrick AL, Jayson MIV, Freemont AJ (1998) TGF-β. A role in systemic sclerosis? J Pathol 184: 4-6
22. Higley H, Persicichitte K, Chu S, Wagell W, Vancheeswaran R, Black C (1994) Immunocytochemical localization and serologic detection of transforming growth factor β1. Arthritis Rheum 37: 278-288
23. Helman S, Cotton SA, Jayson MIV et al. (1997) Microvascular abnormality and TGFβ in systemic sclerosis skin. Br J Rheumatol 36: 30
24. Susol E, Rands AL, Herrick A et al. (2000) Association of markers for TGFbeta3, TGFbeta2 and TIMP1 with systemic sclerosis. Rheumatology 39: 1332-1336
25. Ichiki Y, Smith E, LeRoy EC, Trojanowska M (1995) Different effects of basic fibroblast growth factor and transforming growth factor-beta on the two platelet-derived growth factor receptors' expression in scleroderma and healthy human dermal fibroblasts. J Invest Dermatol 104: 124-127
26. Sfikakis PP, McCune BK, Tsokos M, Aroni K, Vayiopoulos G, Tsokos GC (1993) Immunohistological demonstration of transforming growth factor-beta isoforms in the skin of patients with systemic sclerosis. Clin Immunol Immunopathol 69: 199-204
27. Subba Rao PV, Friedman MM, Atkins FM, Metcalfe DD (1983) Phagocytosis of mast cell granules by cutured fibroblasts. J Ýmmunol 130: 341-349
28. Sueki H, Whitaker D, Buchsbaum M, Murphy GF (1993) Novel interactions between dermal dendrocytes and mast cells in human skin. Lab Invest 69: 160-172
29. Irani AA, Gruber BL, Kaufman LD et al. (1992) Mast cell changes in scleroderma. Presence of MC T cells in the skin and evidence of mast cell activation. Arthritis Rheum 35: 933-939
30. Akimoto S, Ishikawa O, Igarashi Y, Kurosawa M, Miyachi Y (1998) Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation. Br J Dermatol 138: 399-406
31. Walker M, Harley R, Maize J, DeLustro F, LeRoy EC (1985) Mast cells and their degranulation in the Tsk mouse model of scleroderma. Proc Soc Exp Biol Med 180: 323-328
32. Claman HN (1989) Mast cell changes in a case of rapidly progressive scleroderma- ultrastructural analysis. J Invest Dermatol 92: 290-295
33. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (Scleroderma). Artritis Rheum 1980; 23:581-590
34. LeRoy EC, Black C, Fleischmajer R et al. (1988) Scleroderma (systemic sclerosis): classification, subsets, pathogenesis. J Rheumatol 15: 202-205